Arrowhead Pharmaceuticals <ARWR.O>: Morgan Stanley raises target price to $120 from $100
ARWR•Related News
EU urges Houthis to stop attacks in Red Sea
XLE•
Albertsons consolidates 11 divisions into four regions in operating overhaul
ACI•
Arrow Financial Q2 FY26 net income drops 18.52% to $11 million; EPS falls to $0.66
AROW•
BRC Group Holdings schedules Q2 2026 earnings call
RILY•
EU targets Russian banks in new sanctions package over Ukraine war
XLF•